 |
|
|
|
 |
|
|
| Article 1 to 5 out of 5 concerning Targeted Genetics Corporation
|
-
Zambia begins first preventive HIV vaccine trial
(04/28/2006)
Targeted Genetics Corporation, the Zambia Emory HIV Research Project (ZEHRP) and the International AIDS Vaccine Initiative (IAVI) announced the initiation of a clinical trial in Zambia to test the safety and immunogenicity of tgAAC09, a preventive ...
-
HIV/AIDS Vaccine Trial in Entebbe, Uganda
(02/08/2006)
Cooperation between the Uganda Virus Research Institute (UVRI), the International AIDS Vaccine Initiative (IAVI) and Targeted Genetics
Targeted Genetics Corporation, The Uganda Virus Research Institute (UVRI), and the International AIDS Vaccine Initiative (IAVI) announced the start of a Phase II clinical trial in Uganda to evaluate the safety and immunogenicity of tgAAC09, a ...
-
Targeted Genetics announces issuance of additional adeno-associated virus (AAV) vector technology patent
(09/01/2005)
Targeted Genetics Corporation announced the issuance of an additional patent related to the Company's adeno-associated virus (AAV) vector technology. U.S. patent #6,936,466, titled "Transcriptionally Activated AAV Inverted Terminal Repeats (ITRs) ...
-
Targeted Genetics Announces New Patent for Hyperlipidemia
(05/13/2005)
Targeted Genetics Corporation announced issuance of U.S. patent #6,887,463, entitled, "Methods and Compositions for Gene Therapy for the Treatment of Defects in Lipoprotein Metabolism." This patent covers adenovirus AAV (Ad-AAV) hybrid vectors ...
-
Germany Begins its First AIDS Vaccine Trial, Partnering with IAVI
(02/17/2004)
Berlin - German scientists, working as part of an international partnership, are beginning the country's first human trial of a vaccine candidate designed to prevent AIDS. A preventive vaccine is widely considered the best hope to stop the ...
|
|
|
|
|
Top
